These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15065137)

  • 1. Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study.
    Saia F; Lemos PA; Arampatzis CA; Hoye A; McFadden E; Sianos G; Smits PC; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):455-60. PubMed ID: 15065137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors of cardiac events after implantation of sirolimus-eluting stents for treatment of in-stent restenosis.
    Le Feuvre C; Montalescot G; Rosey G; Collet JP; Beygui F; Choussat R; Gelft G; Monségu J; Ohanessian A; Spaulding C; Drobinski G; Metzger JP
    Int J Cardiol; 2006 May; 109(2):207-12. PubMed ID: 15993962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.
    Lemos PA; Lee CH; Degertekin M; Saia F; Tanabe K; Arampatzis CA; Hoye A; van Duuren M; Sianos G; Smits PC; de Feyter P; van der Giessen WJ; van Domburg RT; Serruys PW
    J Am Coll Cardiol; 2003 Jun; 41(11):2093-9. PubMed ID: 12798587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
    Vijayakumar M; Lemos PA; Hoye A; Ong AT; Aoki J; Granillo GR; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Cummins PA; Serruys PW
    Am J Cardiol; 2004 Oct; 94(7):909-13. PubMed ID: 15464675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of sirolimus-eluting coronary stents in routine clinical practice.
    Goy JJ; Urban P; Seydoux C; De Benedetti E; Stauffer JC
    Catheter Cardiovasc Interv; 2004 May; 62(1):26-9; discussion 62. PubMed ID: 15103595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study.
    Saia F; Lemos PA; Lee CH; Arampatzis CA; Hoye A; Degertekin M; Tanabe K; Sianos G; Smits PC; McFadden E; Hofma SH; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Circulation; 2003 Oct; 108(16):1927-9. PubMed ID: 14557354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries (a SES-SMART substudy).
    Ortolani P; Ardissino D; Cavallini C; Bramucci E; Indolfi C; Aquilina M; Marzocchi A
    Am J Cardiol; 2005 Nov; 96(10):1393-8. PubMed ID: 16275185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events.
    Marzocchi A; Piovaccari G; Manari A; Aurier E; Benassi A; Saia F; Casella G; Varani E; Santarelli A; Guastaroba P; Grilli R; Maresta A
    Am J Cardiol; 2005 Jun; 95(12):1409-14. PubMed ID: 15950561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.
    Saia F; Lemos PA; Arampatzis CA; Hoye A; Degertekin M; Tanabe K; Sianos G; Smits PC; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Heart; 2004 Oct; 90(10):1183-8. PubMed ID: 15367519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.
    Aoki J; Nakazawa G; Tanabe K; Hoye A; Yamamoto H; Nakayama T; Onuma Y; Higashikuni Y; Otsuki S; Yagishita A; Yachi S; Nakajima H; Hara K
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):380-6. PubMed ID: 17195199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of everolimus-eluting stent with a bioresorbable polymer coating for treatment of recurrent in-stent restenosis.
    Honda H; Meguro T; Takizawa K; Isoyama S
    J Invasive Cardiol; 2005 Feb; 17(2):112-5. PubMed ID: 15687539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results.
    Orlic D; Bonizzoni E; Stankovic G; Airoldi F; Chieffo A; Corvaja N; Sangiorgi G; Ferraro M; Briguori C; Montorfano M; Carlino M; Colombo A
    J Am Coll Cardiol; 2004 Apr; 43(7):1154-60. PubMed ID: 15063422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty.
    Cheneau E; Rha SW; Kuchulakanti PK; Stabile E; Kinnaird T; Torguson R; Pichard AD; Satler LF; Kent KM; Waksman R
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):469-72. PubMed ID: 15988741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus-eluting stent in chronic total occlusion: the SICTO study.
    Lotan C; Almagor Y; Kuiper K; Suttorp MJ; Wijns W
    J Interv Cardiol; 2006 Aug; 19(4):307-12. PubMed ID: 16881976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.
    Rensing BJ; Vos J; Smits PC; Foley DP; van den Brand MJ; van der Giessen WJ; de Feijter PJ; Serruys PW
    Eur Heart J; 2001 Nov; 22(22):2125-30. PubMed ID: 11686669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overstretching undersized drug-eluting stents: a temporary solution.
    Bass TA
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):461-2. PubMed ID: 15065138
    [No Abstract]   [Full Text] [Related]  

  • 20. Day in and day out.
    Holmes DR
    Catheter Cardiovasc Interv; 2004 May; 62(1):30. PubMed ID: 15103596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.